CEO and President and Director
Mr. Rajiv De Silva is President Chief Executive Officer and a Director of Endo International Public Limited Company. Prior to joining Endo in March 2013 Mr. De Silva joined Endo Health Solutions as Chief Executive Officer and a Director in March 2013 and had served as the President of Valeant Pharmaceuticals International Inc. from October 2010 to January 2013 and served as its Chief Operating Officer Specialty Pharmaceuticals from January 2009 until January 2013. At Valeant he was responsible for all specialty pharmaceutical operations including sales and marketing research and development manufacturing and business development. Prior to joining Valeant Mr. De Silva held various leadership positions with Novartis. He served as President of Novartis Vaccines USA and Head Vaccines of the Americas at Novartis. During this time he played a key leadership role at Novartis Vaccines Diagnostics Division. Mr. De Silva also served as President of Novartis Pharmaceuticals Canada. He originally joined Novartis as Global Head of Strategic Planning for Novartis Pharma AG in Basel Switzerland. Prior to his time at Novartis Mr. De Silva was a Principal at McKinsey Company and served as a member of the leadership group of its Pharmaceuticals and Medical Products Practice. He has broad international experience having managed businesses in the United States Europe Canada Latin America Asia South Africa and AustraliaNew Zealand. Mr. De Silva was a Director of AMAG Pharmaceuticals Inc. and is currently a Member of the Board of Trustees at Kent Place School in Summit NJ.
Age: 48De Silva was a Director of AMAG Pharmaceuticals, Inc., a public specialty pharmaceutical company, and is currently a Member of the Board of Trustees at Kent Place School in Summit, NJ. He holds a BS in Engineering, Honors from Princeton University, a MS from Stanford University and a MBA with Distinction from the Wharton School at the University of Pennsylvania.